Baseline characteristics of the study groups
| Ropivacaine group (n=35) | Bupivacaine group (n=35) | Lidocaine group (n=35) | Lido+bupi group (n=35) | p Value | |
|---|---|---|---|---|---|
| Age (years) | 64.31±9.74 | 56.46±11.86 | 58.54±13.06 | 61.86±12.17 | 0.03 |
| Sex (male/female) | 15/20 | 19/16 | 18/17 | 14/21 | 0.583 |
| Eye (left/right) | 9/26 | 15/20 | 17/18 | 16/19 | 0.151 |
| Weight (kg) | 67.57±9.8 | 69.27±8.26 | 65.97±9.8 | 65.19±13.96 | 0.391 |
| Type of disease (PDR/RRD/macular diseases/RVO/others) | 3/18/11/1/2 | 5/18/9/0/3 | 10/11/9/1/4 | 7/13/12/2/1 | 0.489 |
| Patients with high myopia (≥6D), n | 7 | 4 | 5 | 4 | 0.706 |
| Patients who underwent phaco-ppv surgery, n | 31 | 29 | 26 | 33 | 0.112 |
| Duration of surgery (min) | 86.06±26.09 | 81.66±23.49 | 78.49±27.55 | 87.17±24.6 | 0.458 |
PDR, proliferative diabetic retinopathy; ppv, pars plana vitrectomy; RRD, rhegmatogenous retinal detachment; RVO, retinal vein occlusion.